Literature DB >> 16721558

CCR5 interactions with the variable 3 loop of gp120.

Kelby B Napier1, Zi-xuan Wang, Stephen C Peiper, John O Trent.   

Abstract

The G-protein coupled receptor CCR5 functions pathologically as the primary co-receptor for macrophage tropic (R5) strains of HIV-1. The interactions responsible for co-receptor activity are unknown. Molecular-dynamics simulations of the extracellular and adjacent transmembrane domains of CCR5 were performed with explicit solvation utilizing a rhodopsin-based homology model. The functional unit of co-receptor binding was constructed via docking and molecular-dynamics simulation of CCR5 and the variable 3 loop of gp120, which is a dominant determinant of co-receptor utilization. The variable 3 loop was demonstrated to interact primarily with the amino terminus and the second extracellular loop of CCR5, providing novel structural information regarding the co-receptor-binding site. Alanine mutants that alter chemokine binding and co-receptor activity were examined. Molecular-dynamics simulations with and without the variable 3 loop of gp120 were able to rationalize the activities of these mutants successfully, providing support for the proposed model. Based on these results, the global complex of CCR5, gp120 including the V3 loop and CD4, was investigated. The utilization of computational analysis, in combination with molecular biological data, provides a powerful approach for understanding the use of CCR5 as a co-receptor by HIV-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721558     DOI: 10.1007/s00894-006-0117-z

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  62 in total

1.  A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1.

Authors:  S J Siciliano; S E Kuhmann; Y Weng; N Madani; M S Springer; J E Lineberger; R Danzeisen; M D Miller; M P Kavanaugh; J A DeMartino; D Kabat
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

2.  The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism.

Authors:  A J Cann; M J Churcher; M Boyd; W O'Brien; J Q Zhao; J Zack; I S Chen
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Definition of general topological equivalence in protein structures. A procedure involving comparison of properties and relationships through simulated annealing and dynamic programming.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1990-03-20       Impact factor: 5.469

4.  CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.

Authors:  W K Wang; T Dudek; Y J Zhao; H G Brumblay; M Essex; T H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

5.  The complete Consensus V3 loop peptide of the envelope protein gp120 of HIV-1 shows pronounced helical character in solution.

Authors:  W F Vranken; M Budesinsky; F Fant; K Boulez; F A Borremans
Journal:  FEBS Lett       Date:  1995-10-23       Impact factor: 4.124

6.  Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1.

Authors:  B J Doranz; Z H Lu; J Rucker; T Y Zhang; M Sharron; Y H Cen; Z X Wang; H H Guo; J G Du; M A Accavitti; R W Doms; S C Peiper
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry.

Authors:  T Dragic; A Trkola; S W Lin; K A Nagashima; F Kajumo; L Zhao; W C Olson; L Wu; C R Mackay; G P Allaway; T P Sakmar; J P Moore; P J Maddon
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Molecular cloning and functional expression of a new human CC-chemokine receptor gene.

Authors:  M Samson; O Labbe; C Mollereau; G Vassart; M Parmentier
Journal:  Biochemistry       Date:  1996-03-19       Impact factor: 3.162

9.  Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.

Authors:  F Sallusto; D Lenig; C R Mackay; A Lanzavecchia
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

10.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  9 in total

1.  Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop.

Authors:  Phanourios Tamamis; Christodoulos A Floudas
Journal:  Biophys J       Date:  2013-09-17       Impact factor: 4.033

2.  HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.

Authors:  Cécile Tremblay; Isabelle Hardy; Richard Lalonde; Benoit Trottier; Irina Tsarevsky; Louis-Philippe Vézina; Michel Roger; Mark Wainberg; Jean-Guy Baril
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

3.  Immunization with wild-type or CD4-binding-defective HIV-1 Env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus.

Authors:  Christopher Sundling; Sijy O'Dell; Iyadh Douagi; Mattias N Forsell; Andreas Mörner; Karin Loré; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

4.  Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist vicriviroc.

Authors:  Robert A Ogert; Lei Ba; Yan Hou; Catherine Buontempo; Ping Qiu; Jose Duca; Nicholas Murgolo; Peter Buontempo; Robert Ralston; John A Howe
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

5.  Effects of partial deletions within the human immunodeficiency virus type 1 V3 loop on coreceptor tropism and sensitivity to entry inhibitors.

Authors:  Katrina M Nolan; Andrea P O Jordan; James A Hoxie
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

6.  Investigation of Inhibition Mechanism of Chemokine Receptor CCR5 by Micro-second Molecular Dynamics Simulations.

Authors:  Ramin Ekhteiari Salmas; Mine Yurtsever; Serdar Durdagi
Journal:  Sci Rep       Date:  2015-08-24       Impact factor: 4.379

7.  Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.

Authors:  Phanourios Tamamis; Christodoulos A Floudas
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

Review 8.  Viral dUTPases: Modulators of Innate Immunity.

Authors:  Maria Eugenia Ariza; Brandon Cox; Britney Martinez; Irene Mena-Palomo; Gloria Jeronimo Zarate; Marshall Vance Williams
Journal:  Biomolecules       Date:  2022-01-28

9.  Insights into the structure, correlated motions, and electrostatic properties of two HIV-1 gp120 V3 loops.

Authors:  Aliana López de Victoria; Phanourios Tamamis; Chris A Kieslich; Dimitrios Morikis
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.